
How To Lock In Yields Up To 17.1% In Historically Cheap Small Caps
Small-cap stocks haven't been this cheap in decades. This valuation advantage gets interesting when we add big fat dividends and today, we'll discuss five cheap small caps yielding between 8.3% and 17.1%. (That's no typo by the way—we only talk serious dividends here at Contrarian Outlook!)
The Apples, Google and Microsofts of the world are priced like luxury goods. Smaller stocks, meanwhile, have been left at the discount rack. Let's shop:
The valuation spread between the S&P 500 and S&P 600 hasn't been this wide since Bill Clinton was wondering whether dot-com was one word or two. Is a bust to follow again or are these big yields from small stocks really spectacular deals? Let's explore.
Israel-based Platytika Holding (PLTK) is a gamemaker that primarily makes casino-themed titles for countries on just about every continent. Here in the U.S., Playtika's best-known titles include Bingo Blitz, Redecor and Domino Dreams.
Playtika has done quite a bit of building by acquisition, purchasing Seriously, JustPlay.LOL, Youda Games, Innplay Labs and, most recently, SuperPlay, among others. (It tried to buy Angry Birds maker Rovio in 2023, but the deal eventually fell apart.)
Playtika hasn't been a dividend stock for very long—it initiated its dividend program in late February 2024. About a year ago, when I examined PLTK among other 'inaugural dividends,' I mentioned its 10-cent-quarterly dividend translated into a nice 5% yield, but also more than 60% of the company's estimated earnings for 2024. By the time all was said and done, it ended up being closer to 70% of adjusted profits for last year.
Fast-forward to today: PLTK hasn't raised its payout, but it now yields north of 8%. This is the 'wrong way' to raise a dividend.
PLTK Total Returns
Ycharts
As I said in my previous writeup, the mobile game market is brutal, especially among the 'free to play' titles that Playtika specializes in. PLTK had been suffering from years of profit declines and flat sales, and sure enough, 2024 saw another drop in earnings and a modest decline in sales.
And yet … the few pros who cover the stock are quite bullish about what comes next. While revenue growth estimates for the next two years aren't much to scream over, they're looking for a 32% jump in profits this year, and a respectable 23% improvement in 2026. Meanwhile, PLTK's woeful performance has driven the dividend higher and its valuation down to a dirt-cheap 6 times forward earnings.
Still, Playtika is asking for a lot of faith in its growth prospects while (so far) providing very little evidence.
Carlyle Secured Lending (CGBD) is a business development company (BDC) that's externally managed by a subsidiary of multinational asset manager Carlyle Group (CG).
CGBD invests primarily in U.S. middle market companies with between $25 million and $100 million in annual EBITDA. And it predominantly deals in first-lien debt (83%), though it has single-digit exposure to second-lien debt, equity investments and even investment funds. Its 138 portfolio companies cover a couple dozen industries, including healthcare/pharmaceuticals, software, consumer services, and business services.
Carlyle Secured Lending came public in 2017. And as we neared the end of 2024, I noted that shares had and spent most of their time putting up downright excellent returns.
Things have changed—drastically!—since then.
CGBD Total Returns
Ycharts
What went wrong?
Two earnings reports have revealed some growing cracks in Carlyle's armor. In February, profits came in below estimates, thanks largely to a markdown on hotel management company Aimbridge Hospitality. It also doubled the number of companies on non-accrual (loans that are delinquent for a prolonged period, usually 90 days), from two to four. In May, the company reported disappointing earnings again, and an additional company went on non-accrual, bringing non-accruals up to 1.6% of the total portfolio at fair value.
More importantly, the company announced it would only pay a base dividend of 40 cents per share. That's problematic for two reasons:
Based on net investment income (NII) estimates for the rest of the year, dividend coverage could be tight; it's possible the company might need to rely on 'spillover' income to cover the payout for at least a quarter or two.
CGBD is just a couple months removed from a potentially beneficial merger with another BDC, Carlyle Secured Lending III; even without any more specials, its base dividend translates into an 11%-plus yield; and shares now trade at a nice 16% discount to net asset value (NAV). But I'd like to see signs that CGBD is correcting its recent operational slide.
Bain Capital Specialty Finance (BCSF) is a diversified BDC that provides a variety of financing solutions to 175 portfolio companies primarily in North America, but also Europe and Australia (a rarity for many BDCs).
The lion's share of Bain Capital's investments are first-lien in nature—in addition to 64% exposure directly through portfolio companies, it also has almost 16% more through its investment vehicles. It also deals in equity and preferred equity interest, as well as second-lien and subordinated debt.
Unlike CGBD, Bain Capital hasn't exactly lit the industry on fire, but it has caught its stride over the past couple of years. Other reasons to like it? A low cost of debt, a higher-than-average portfolio yield (made even better by its joint ventures), investment-grade debt and an 11% discount to NAV.
However I'm nervous about its dividend situation.
Dividend coverage has been a strength for the past couple of years, but that could be changing. In 2024, Bain Capital stopped a short streak of dividend hikes and kept its 42-cent regular dividend in place. It instead began paying 3-cent quarterly special dividends, which it has kept up with ever since.
That 45 cents quarterly comes out to $1.80 per share in annual dividends.
However, analysts expect net investment income to drop from $2.09 per share in 2024 to $1.84 per share this year and $1.82 per share in 2026. That means dividend ratios in the 98%-99% range, which leaves almost no room for error. If BCSF does run into difficulty over the next couple of years, we could see the special dividends reduced or taken away outright—certainly a better look than having to cut a regular dividend, but the practical end result is still less income, even if temporarily.
On the other hand, the base-and-special system gives BCSF room to reward us more if Wall Street's expectations prove overly pessimistic.
Let's move to another high-yield corner of the market: mortgage real estate investment trusts (mREITs).
For the unfamiliar: The typical REIT deals in physical properties—apartments, strip malls, hospitals, casinos. But mortgage REITs deal in 'paper' real estate. They borrow at low short-term rates, lend that cash out in the form of mortgages based on long-term rates, then pocket the difference.
If 'long' rates (like those on the 10-year Treasury) are steady or, better yet, declining, that's great news for mREITs. New loans pay less, so their existing loans become more valuable.
That's been a mixed bag for mREITs in 2025, which enjoyed declining rates for the first couple months of the year, but have been suffering from a rebound ever since.
First up is Two Harbors Investment (TWO), which deals in mortgage servicing rights (MSRs), agency residential mortgage-backed securities (RMBSs) and other financial assets. It also owns an operational platform, RoundPoint Mortgage Servicing LLC, and it has a direct-to-consumer originations business that's still in its early innings.
Whenever we see a yield near 20%, it's almost always caused by a sharp decline in share prices. That's very much the case with Two Harbors, whose shares traded in the $60s before collapsing during COVID, only mildly rebounded, then deteriorated ever since to current prices around $10 per share.
That action pretty accurately reflected a miserable operating picture:
TWO Dividend
Ycharts
Still, we're talking about a 17%-plus yield. If there's any sort of redeeming value, it's worth looking into. Well, Two Harbors has been working on lowering its debt-to-equity ratio, the company's book value ticked up in the most recent quarter, and it trades at a low 70% of that (still relatively decimated) book value.
But all of those positive bullet points have been canceled out by an 8-K filed near the end of May.
Two Harbors announced it was taking a $198.9 million charge related to litigation dating back to 2020 against PRCM Advisers, its former external manager. That comes out to roughly $1.90 per share, or 13% of TWO's last reported book value of $14.66 per share.
The potential danger is that this significant hit to book value could impact earnings available for distribution (EAD), putting its current dividend rate of 45 cents per share at risk. While the company doesn't report earnings until July, TWO typically announces its dividends in the middle of the month prior to the month in which it reports—so, in this case, we might know by sometime in mid-June.
Too much dividend drama.
Take Franklin BSP Realty Trust (FBRT), a mortgage REIT dealing in commercial mortgage-backed securities (CMBSs). Multifamily is king here, at more than 70% of the portfolio, but FBRT is happy to take on just about any type of commercial property—it also holds loans in hospitality, industrial, office, retail and other sectors.
Virtually all of its portfolio is senior debt, and nearly 90% of that is floating-rate in nature. Collateralized loan obligations are the bulk of its financing sources at a hair over 80%, but Franklin BSP Realty Trust also has 11% exposure to warehouse lending (credit lines extended by banks to originate mortgages), 5% to repurchase agreements (repo), and sprinklings of unsecured debt and asset-specific financing.
FBRT shares are down by double digits year-to-date, but now trade at an attractive 28% discount to book and a P/E of around 7 based on 2026 earnings estimates, which is pretty low among mREITs. And there are reasons for optimism—chiefly, the looming July close on the acquisition of NewPoint Holdings JV LLC. The deal to absorb this privately held commercial real estate finance company could set Franklin apart from other commercial mREITs.
Again, though, the dividend situation is perhaps shakier than many of us would want.
For one, the payout hasn't budged since the company started trading in 2021.
Also problematic—real-estate owned (basically, foreclosures) and short-term non-market financing have been dragging on earnings. On the most recent conference call, CFO Jerome Baglien said, 'While we believe in the long-term earning power of the company to cover the dividend, if REO sales slow or volatile market conditions persist, it could be prudent to revisit our dividend in the short term.'
There is a little good news: If earnings expectations stay on track, on the other side of FBRT's short-term drag is a path to more solid dividend coverage longer-term.
Brett Owens is Chief Investment Strategist for Contrarian Outlook. For more great income ideas, get your free copy his latest special report: How to Live off Huge Monthly Dividends (up to 8.7%) — Practically Forever.
Disclosure: none
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
You could cut the tension with a needle—7 SteamDB changes in the past week have Silksong hopefuls wondering if the final hour is upon us
When you buy through links on our articles, Future and its syndication partners may earn a commission. Silksong may, after many long years, finally be releasing—or it may not be. A shadowdrop could be arriving tomorrow, or our eternal vigil may never end. It's either the final 24 hours, or time has no meaning anymore. One thing's for certain: SteamDB has some updates. In addition to the updates released earlier this week, which included achievement data for multiple languages, Silksong has had support for Windows, Mac, and Linux added, visible via SteamDB. At the time of writing, Silksong's minimum requirements don't list Mac or Linux as possible platforms, however, Steam does provide support for them, and developers can prep their store pages to send out platform-specific packages. As always, the Silksong subreddit is being delightfully normal about the news. In one thread, you can even see the ever-cynical doubters (we're well past the point of tribalistic factions) starting to crack. "FUCK MY FLAIR SILKSONG TOMORROW," roars one frantic switcher. "I... CANT... DENY... IT... ANY... LONGER!" writes another, with the tone of the Incredible Hulk swelling out of his shirt. On one hand, it is mighty suspicious that the games' Steam page would receive such a ferocious flurry of updates—seven in total, including this one—before Summer Game Fest. With a bevvy of announcements to come, the idea that Team Cherry's doing some preparatory updating before finally releasing the dang thing isn't entirely out of the question. On the other hand, a few SteamDB updates aren't substantial proof of anything if you aren't scrabbling for every scrap of hope you can. Almost no game since Elden Ring has had this much feverish hype built up behind it and, in a way, the cultish chanting is outstripping what Silksong is likely bound to be: A very good metroidvania. Which, given I've played several since Hollow Knight, is only saying so much. If Team Cherry does do the funniest thing it can and shadowdrop Silksong in a manner of hours, it'll mark the end to all doubting and hoping, all coping and copium. No more daily Silksong news, no more crossed fingers, no more Silkposts. Bait used to be believable, but if it's the dawn of the final day, it shall be absent entirely. All I can say is, if this is indeed the end? Gentlebugs, it has been an honour. 2025 games: This year's upcoming releasesBest PC games: Our all-time favoritesFree PC games: Freebie festBest FPS games: Finest gunplayBest RPGs: Grand adventuresBest co-op games: Better together


Business Insider
34 minutes ago
- Business Insider
The Week That Was, The Week Ahead: Macro & Markets, June 8, 2025
Everything to Know about Macro and Markets Stocks clocked in large weekly gains, returning to positive territory year-to-date. The Dow Jones Industrial Average (DJIA) rose by 1.17%, the S&P 500 (SPX) increased by 1.50%, and the tech-heavy Nasdaq-100 (NDX) gained 1.97% for the week. The S&P 500 finished more than 20% above April's low, reclaiming the 6,000 mark first reached in February, although it remained about 2% shy of its record high. Confident Investing Starts Here: Macro Steers the Markets The week began on a positive note, losing some steam in the second half. The weakness in PMI reports – with the manufacturing activity contracting for a third month in a row and services activity shrinking for the first time in 11 months – infused some gloom. However, Friday saw stocks find their footing again on solid job gains, which allayed fears about an imminent economic downturn. U.S. jobs growth stayed strong in May, climbing 139,000 with unemployment unchanged at 4.2%. Although the March and April reports were revised downward, May's report reassured investors, as it reflected a very gradual cooling of the labor market. Still, diving into the job report's details, a stronger-than-expected wage growth continues to put a floor under inflation. This supports the Federal Reserve's 'wait and see' stance, despite President Trump's demands for a cut. According to the CME FedWatch Tool, the chances of a June cut are nil, and July's rate decrease looks increasingly improbable. Prices in interest rate futures markets imply that investors expect two quarter-point rate cuts by year-end, with the first cut not expected until September. Wrapping Up the Season Despite tariff headwinds and macro volatility, S&P 500 companies delivered solid results last quarter. Index members reported 12.9% year-over-year earnings growth – the second straight double-digit increase. 78% of firms – above the five-year average – exceeded EPS estimates. However, the number of companies issuing negative EPS guidance (68) was also above the average. In Q1, the Healthcare sector reported the highest earnings growth, 43%, leaving the Magnificent Seven cohort's 27.7% increase in the dust. In fact, Mag 7's earnings growth rate was below the average (32.1%) of the previous three quarters. Still, three members of the Magnificent bunch – Alphabet (GOOGL), Amazon (AMZN), and Nvidia (NVDA) – are among the top five contributors to earnings growth for the S&P 500 for the first quarter. Interestingly, Bristol Myers Squibb (BMY) and Gilead Sciences (GILD) were the other top contributors. Stocks That Made the News ▣ Tesla (TSLA) lost nearly 15% over the week following the ugly social media spat between Elon Musk and President Donald Trump. The feud flared up over the impending budget bill, with Musk calling it 'disgusting', and followed by Trump's threat to take away billions of dollars in government subsidies and contracts awarded to Musk's businesses. Although shares rebounded on Friday as Musk and Trump moved to cool tensions, the spat cost Tesla over $150 billion loss in market cap. ▣ Broadcom (AVGO) fell on Friday, wiping out its weekly gain, after the chip giant only narrowly surpassed analyst revenue and expectations. In addition, its current quarter revenue guidance was also just above consensus. Solid, but not a blowout quarter and outlook, weighed on shares that recently hit all-time highs. Still, the company delivered on the AI narrative, reporting surging demand and upping AI networking revenue guidance. ▣ Microsoft (MSFT) continued its climb, hitting a fresh record on Friday as analysts raised price targets on acceleration in Azure and AI-related revenue growth. According to Goldman Sachs, Microsoft's cloud revenue could more than double by 2029. The tech leader's market cap has reached $3.5 trillion, surpassing that of Nvidia (NVDA) and making MSFT the largest company in the world. ▣ Lululemon (LULU) shares dove by 20% on Friday, capping large weekly losses, despite earnings beat. The apparel retailer cut guidance on macroeconomic uncertainty and the impact of tariffs that might force LULU to increase prices. ▣ DocuSign (DOCU) was another notable decliner, sinking nearly 19% post earnings. The company reported a strong financial performance, but a miss on billings raised investor fears about future growth. The Q1 2025 earnings season is practically over, but several notable earnings releases are still scheduled for the next few days. These include Casey's General (CASY), Oracle (ORCL), Chewy (CHWY), and Adobe (ADBE).
Yahoo
38 minutes ago
- Yahoo
Cathie Wood sells $22.8 million of hot stock near all-time highs
Cathie Wood sells $22.8 million of hot stock near all-time highs originally appeared on TheStreet. Cathie Wood has long been aggressive in hunting tech stocks that she believes will have a 'disruptive' impact on the future world. However, she sometimes sells a stock when it is high to secure gains. In the past week, the head of Ark Investment Management sold a popular AI stock that has surged nearly 70% year-to-date. 💵💰Don't miss the move: Subscribe to TheStreet's free daily newsletter 💰💵 Cathie Wood's investments have had a volatile ride this year, swinging from strong gains to sharp losses, and now back to outperforming the broader market. In January and February, the Ark funds rallied as investors bet on the Trump administration's potential deregulation that could benefit Wood's tech bets. But the funds stumbled in the following weeks, underperforming sharply as several of its top holdings —especially Tesla, its largest position — declined amid macroeconomic and trade policy uncertainties. Now, the fund is regaining momentum. As of June 6, the flagship Ark Innovation ETF () is up 6.11% year-to-date, outpacing the S&P 500's 2.02% gain. Wood gained a remarkable 153% in 2020, which helped build her reputation and attract loyal investors. Still, her long-term performance has made many others skeptical of her aggressive style. As of June 6, Ark Innovation ETF, with $5 billion under management, has delivered a five-year annualized return of negative 0.5%. In comparison, the S&P 500 has an annualized return of 15.18% over the same period. Wood's investment strategy is straightforward: Her Ark ETFs typically buy shares in emerging high-tech companies in fields such as artificial intelligence, blockchain, biomedical technology and robotics. Wood says these companies have the potential to reshape industries, but their volatility leads to major fluctuations in Ark funds' Ark Innovation ETF wiped out $7 billion in investor wealth over the 10 years ending in 2024, according to an analysis by Morningstar's analyst Amy Arnott. That made it the third-biggest wealth destroyer among mutual funds and ETFs in Arnott's ranking. Wood said the U.S. is coming out of a three-year 'rolling recession' and heading into a productivity-led recovery that could trigger a broader bull market. In a letter to investors published on April 30, she dismissed predictions of a recession dragging into 2026, as she expects "more clarity on tariffs, taxes, regulations, and interest rates over the next three to six months." "If the current tariff turmoil results in freer trade, as tariffs and non-tariff barriers come down in tandem with declines in other taxes, regulations, and interest rates, then real GDP growth and productivity should surprise on the high side of expectations at some point during the second half of this year," she wrote. She also struck an optimistic tone for tech stocks. "During the current turbulent transition in the US, we think consumers and businesses are likely to accelerate the shift to technologically enabled innovation platforms including artificial intelligence, robotics, energy storage, blockchain technology, and multiomics sequencing," she said. But not everyone shares Wood's bullish outlook. Her flagship Ark Innovation ETF has seen $2.23 billion in net outflows over the past year through June 5, including nearly $154 million in the last month alone, according to ETF research firm VettaFi. From June 2 to June 5, Wood's Ark funds sold 179,846 shares of Palantir Technologies () , which was valued at roughly $22.8 million. Palantir is known for providing AI-driven data analytics software to the U.S. government, military, and commercial clients worldwide, including JPMorgan Chase, Airbus, and Merck. The company reported stronger-than-expected first-quarter revenue in early May and raised its full-year outlook as demand for AI tools increased. 'We are delivering the operating system for the modern enterprise in the era of AI,' CEO Alex Karp said. While many tech stocks have struggled this year, Palantir has stood out. Its shares are up roughly 69% in 2025 and just hit a record close of $133.17 on June of the recent momentum comes from its government work. Back in May 2024, Palantir won a $480 million, five-year U.S. Army contract to build its Maven Smart System, which is a battlefield AI prototype. Last month, the Defense Department modified the contract, increasing the licensing ceiling from $480 million to $1.275 billion. Palantir's Foundry platform has been adopted by at least four federal agencies, including the Department of Homeland Security and the Department of Health and Human Services, according to a New York Times report published May 30. Fannie Mae also announced a partnership with Palantir in May to work on AI-based fraud detection. However, the New York Times article also raised concerns about the company's relationship with the Trump administration, alleging that the U.S. president could use Palantir's technology to target immigrants and political opponents. The article also claimed that some Palantir employees felt uncomfortable with the company's decision to work with the Trump administration and that it "risks becoming the face of Mr. Trump's political agenda." Palantir responded in a June 3 post on X, denying the accusations. More Palantir Palantir gets great news from the Pentagon Wall Street veteran doubles down on Palantir Palantir bull sends message after CEO joins Trump for Saudi visit 'The recently published article by The New York Times is blatantly untrue,' the company wrote. 'Palantir never collects data to unlawfully surveil Americans.' Palantir remains a core position for Wood even after recent trims. The stock is now the 9th largest holding in the ARK Innovation ETF, accounting for 4.54%. Wood's latest trades in the past week include buying shares of Advanced Micro Devices () , () , Guardant Health () and Veracyte () . At the same time, she trimmed positions in Tesla () , Roblox () , Robinhood () , and Meta Platforms () .Cathie Wood sells $22.8 million of hot stock near all-time highs first appeared on TheStreet on Jun 8, 2025 This story was originally reported by TheStreet on Jun 8, 2025, where it first appeared.